CPSE:CHEMMLife Sciences
ChemoMetec (CPSE:CHEMM) Is Up 12.5% After Dividend Hike and Strong Outlook – Has the Growth Story Evolved?
ChemoMetec A/S recently announced improved full-year financial results for 2024/25, a proposed DKK 7.0 per share dividend totaling DKK 121.8 million, and issued earnings guidance projecting revenue growth for the 2025/26 financial year.
This combination of higher earnings, a larger dividend, and an optimistic outlook highlights ChemoMetec's ongoing focus on both business expansion and shareholder returns.
We'll consider how ChemoMetec's increased dividend proposal adds depth to its...